Lce1a1 inhibitors are a class of chemical compounds that specifically target the Lce1a1 protein, a part of a larger family of proteins known for their unique structures and functions within cellular biology. The Lce1a1 protein, belonging to the Lce (Late Cornified Envelope) protein family, plays a significant role in various biological processes. This protein family is characterized by its involvement in the formation of the cornified envelope, a structure that is critical in the outermost layer of the skin. The Lce proteins, including Lce1a1, are noted for their specific expression patterns and are typically localized in the epidermal layers of the skin. The inhibitors designed to target Lce1a1 are crafted through a meticulous process of molecular engineering, ensuring specificity and efficacy in their interaction with the protein.
The development of Lce1a1 inhibitors involves advanced techniques in medicinal chemistry and molecular biology. Researchers focus on understanding the precise molecular structure of the Lce1a1 protein, which is crucial for the design of effective inhibitors. The binding interaction between these inhibitors and the Lce1a1 protein is a key area of study, as it determines the inhibitor's efficiency and specificity. This interaction is often characterized by the formation of a complex between the inhibitor and specific sites on the protein, a process that requires precise alignment of molecular structures and often involves the formation of hydrogen bonds and other types of molecular interactions. The design of Lce1a1 inhibitors also takes into account factors such as the compound's stability, solubility, and its ability to reach the target site within biological systems. This involves a careful balance of hydrophobic and hydrophilic properties, as well as considerations for the compound's overall molecular size and shape. The intricate process of designing these inhibitors reflects the complexity and specificity required to effectively target the Lce1a1 protein, highlighting the advanced state of current biochemical and pharmacological research techniques.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound is a DNA methyltransferase inhibitor, which can lead to hypomethylation of DNA and potentially upregulate or downregulate gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is a histone deacetylase inhibitor that can change chromatin structure and thereby influence gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate also acts as a histone deacetylase inhibitor, modifying chromatin and affecting transcription. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is another DNA methyltransferase inhibitor, preventing DNA methylation and potentially altering gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
This compound binds to DNA and inhibits RNA synthesis, which could affect the expression of several genes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine affects DNA and RNA polymerase activity and can alter the expression of genes and protein production. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a bromodomain inhibitor that can affect transcriptional regulation and thereby potentially downregulate gene expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective histone deacetylase inhibitor that can modify chromatin structure and gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is used to induce DNA hypomethylation and may alter the expression of genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor, which can lead to chromatin remodeling and changes in gene expression. | ||||||